Skip to main content
Erschienen in: Pediatric Radiology 8/2019

02.05.2019 | Original Article

Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla

verfasst von: Leah A. Gilligan, Jonathan R. Dillman, Jean A. Tkach, Stavra A. Xanthakos, Jacqueline K. Gill, Andrew T. Trout

Erschienen in: Pediatric Radiology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

T1 relaxation time is a potential magnetic resonance imaging (MRI) biomarker for fibrosis and inflammation of the solid abdominal organs. However, normal T1 relaxation times of the solid abdominal organs have not been defined for children.

Objective

The purpose of this study was to measure T1 relaxation times of the liver, pancreas and spleen in healthy children.

Materials and methods

This was an institutional review board-approved study of a convenience sample of prospectively recruited, healthy children ages 7 to 17 years undergoing research abdominal MRI (1.5 or 3 T) as part of a larger research study between February 2018 and October 2018. For the current study, T1 mapping was performed with a Modified Look-Locker sequence covering the upper abdomen. A single reviewer placed freehand regions of interest on the T1 parametric maps in the liver, pancreas and spleen, inclusive of as much parenchyma as possible. Student’s t-tests and linear regression were used to compare T1 values by age and gender.

Results

Thirty-two participants were included (16 female:16 male; mean age: 12.2±3.1 years; n=16 at 1.5 T). Median T1 relaxation times (ms) per organ were liver: 581±64 (1.5 T), 783±88 (3 T); pancreas: 576±55 (1.5 T), 730±30 (3 T), and spleen: 1,172±71 (1.5 T), 1,356±87 (3 T). T1 values were not statistically significantly different between males and females. At both 1.5 and 3 T field strengths, linear regression showed no significant association between age and T1 values for the liver, pancreas and spleen.

Conclusion

We report normal T1 relaxation times for the liver, pancreas and spleen at 1.5 and 3 T in a cohort of healthy children.
Literatur
1.
Zurück zum Zitat Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121CrossRefPubMed Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121CrossRefPubMed
2.
Zurück zum Zitat Serai SD, Trout AT, Miethke A et al (2018) Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol 48:1256–1272CrossRefPubMed Serai SD, Trout AT, Miethke A et al (2018) Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis. Pediatr Radiol 48:1256–1272CrossRefPubMed
3.
Zurück zum Zitat Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging 9:67–81CrossRefPubMed Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging 9:67–81CrossRefPubMed
4.
Zurück zum Zitat Luetkens JA, Klein S, Traber F et al (2018) Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical results. Radiology 288:748–754CrossRefPubMed Luetkens JA, Klein S, Traber F et al (2018) Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical results. Radiology 288:748–754CrossRefPubMed
5.
Zurück zum Zitat Banerjee R, Pavlides M, Tunnicliffe EM et al (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60:69–77CrossRefPubMedPubMedCentral Banerjee R, Pavlides M, Tunnicliffe EM et al (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60:69–77CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Haimerl M, Verloh N, Fellner C et al (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621CrossRefPubMedPubMedCentral Haimerl M, Verloh N, Fellner C et al (2014) MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 4:5621CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Pavlides M, Banerjee R, Sellwood J et al (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 64:308–315CrossRefPubMedPubMedCentral Pavlides M, Banerjee R, Sellwood J et al (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 64:308–315CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Pavlides M, Banerjee R, Tunnicliffe EM et al (2017) Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int 37:1065–1073CrossRefPubMedPubMedCentral Pavlides M, Banerjee R, Tunnicliffe EM et al (2017) Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int 37:1065–1073CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Tunnicliffe EM, Banerjee R, Pavlides M et al (2017) A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified look-locker inversion recovery T1 (shMOLLI-T1 ) in the liver. J Magn Reson Imaging 45:450–462CrossRefPubMed Tunnicliffe EM, Banerjee R, Pavlides M et al (2017) A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified look-locker inversion recovery T1 (shMOLLI-T1 ) in the liver. J Magn Reson Imaging 45:450–462CrossRefPubMed
10.
Zurück zum Zitat Zhou ZP, Long LL, Qiu WJ et al (2017) Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 tesla. BMC Med Imaging 17:20CrossRefPubMedPubMedCentral Zhou ZP, Long LL, Qiu WJ et al (2017) Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 tesla. BMC Med Imaging 17:20CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mojtahed A, Kelly CJ, Herlihy AH et al (2019) Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK biobank sub-study, with an appendix of interesting cases. Abdom Radiol (NY) 44:72–84CrossRef Mojtahed A, Kelly CJ, Herlihy AH et al (2019) Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK biobank sub-study, with an appendix of interesting cases. Abdom Radiol (NY) 44:72–84CrossRef
12.
Zurück zum Zitat Tirkes T, Lin C, Fogel EL et al (2017) T1 mapping for diagnosis of mild chronic pancreatitis. J Magn Reson Imaging 45:1171–1176CrossRefPubMed Tirkes T, Lin C, Fogel EL et al (2017) T1 mapping for diagnosis of mild chronic pancreatitis. J Magn Reson Imaging 45:1171–1176CrossRefPubMed
13.
Zurück zum Zitat Tirkes T, Lin C, Cui E et al (2018) Quantitative MR evaluation of chronic pancreatitis: extracellular volume fraction and MR Relaxometry. AJR Am J Roentgenol 210:533–542CrossRefPubMedPubMedCentral Tirkes T, Lin C, Cui E et al (2018) Quantitative MR evaluation of chronic pancreatitis: extracellular volume fraction and MR Relaxometry. AJR Am J Roentgenol 210:533–542CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Liu A, Wijesurendra RS, Ariga R et al (2017) Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 19(1) Liu A, Wijesurendra RS, Ariga R et al (2017) Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance. J Cardiovasc Magn Reson 19(1)
16.
Zurück zum Zitat Lee DH, Lee JM, Han JK, Choi BI (2013) MR elastography of healthy liver parenchyma: Normal value and reliability of the liver stiffness value measurement. J Magn Reson Imaging 38:1215–1223CrossRefPubMed Lee DH, Lee JM, Han JK, Choi BI (2013) MR elastography of healthy liver parenchyma: Normal value and reliability of the liver stiffness value measurement. J Magn Reson Imaging 38:1215–1223CrossRefPubMed
17.
18.
Zurück zum Zitat Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed Flett AS, Hayward MP, Ashworth MT et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144CrossRefPubMed
19.
Zurück zum Zitat Iles L, Pfluger H, Phrommintikul A et al (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580CrossRefPubMed Iles L, Pfluger H, Phrommintikul A et al (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580CrossRefPubMed
20.
Zurück zum Zitat Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383CrossRefPubMed Miller CA, Naish JH, Bishop P et al (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6:373–383CrossRefPubMed
21.
Zurück zum Zitat Ferreira VM, Piechnik SK, Dall'Armellina E et al (2014) Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 16:36CrossRefPubMedPubMedCentral Ferreira VM, Piechnik SK, Dall'Armellina E et al (2014) Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 16:36CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Messroghli DR, Greiser A, Frohlich M et al (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed Messroghli DR, Greiser A, Frohlich M et al (2007) Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 26:1081–1086CrossRefPubMed
23.
Zurück zum Zitat Messroghli DR, Radjenovic A, Kozerke S et al (2004) Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed Messroghli DR, Radjenovic A, Kozerke S et al (2004) Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52:141–146CrossRefPubMed
24.
Zurück zum Zitat Piechnik SK, Ferreira VM, Dall'Armellina E et al (2010) Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69CrossRefPubMedPubMedCentral Piechnik SK, Ferreira VM, Dall'Armellina E et al (2010) Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 12:69CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Carrick D, Haig C, Rauhalammi S et al (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J 37:1044–1059CrossRefPubMed Carrick D, Haig C, Rauhalammi S et al (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J 37:1044–1059CrossRefPubMed
26.
Zurück zum Zitat Chan W, Duffy SJ, White DA et al (2012) Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging 5:884–893CrossRefPubMed Chan W, Duffy SJ, White DA et al (2012) Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging 5:884–893CrossRefPubMed
27.
Zurück zum Zitat Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484CrossRefPubMed Puntmann VO, Voigt T, Chen Z et al (2013) Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 6:475–484CrossRefPubMed
28.
Zurück zum Zitat Hinojar R, Foote L, Arroyo Ucar E et al (2015) Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 8:37–46CrossRefPubMed Hinojar R, Foote L, Arroyo Ucar E et al (2015) Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 8:37–46CrossRefPubMed
29.
Zurück zum Zitat Bjornerud A, Johansson LO, Briley-Saebo K, Ahlstrom HK (2002) Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange. Magn Reson Med 47:461–471CrossRefPubMed Bjornerud A, Johansson LO, Briley-Saebo K, Ahlstrom HK (2002) Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange. Magn Reson Med 47:461–471CrossRefPubMed
Metadaten
Titel
Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla
verfasst von
Leah A. Gilligan
Jonathan R. Dillman
Jean A. Tkach
Stavra A. Xanthakos
Jacqueline K. Gill
Andrew T. Trout
Publikationsdatum
02.05.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 8/2019
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-019-04411-7

Weitere Artikel der Ausgabe 8/2019

Pediatric Radiology 8/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.